Navigation Links
Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
Date:4/11/2011

WEST BEND, Wis., April 11, 2011 /PRNewswire/ -- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly announces the addition of Aziz Karim, BPharm, PhD, FCP, ABCP to their team as a consultant and advisor to Spaulding's Clinical Pharmacology/Pharmacokinetic department.  

Dr. Karim's expertise lies in the principles of Clinical Pharmacology and rational drug development including the design of drug-drug interaction and bioavailability/bioequivalence studies. With over 30 years of experience in Pharmaceutical Sciences and Clinical Pharmacology, he has contributed to the development and marketing approvals of over 30 NCEs and/or Novel Drug Delivery Systems and has interfaced extensively with global regulatory bodies.  Most recently, Dr. Karim was the Vice President of Global Clinical Pharmacology at Takeda Pharmaceuticals.  Prior to Takeda, he held the role of Distinguished Scientist & Senior Director of Clinical Pharmacology for G.D. Searle & Co. and Pharmacia.

Daniel Selness, General Manager and Senior Vice President of Operations, commented, "Aziz's understanding of early clinical development, ability to design appropriate pharmacology trials/programs, and analysis expertise are wonderful complements to our existing services. Pharmacokinetic design and analysis is an imperative part of NCE development and if not approached correctly, may result in significant delays to programs.  Keeping with our company goals, his experience will continue to improve clinical trials, ultimately leading to safer drugs in the marketplace." 

CEO Randol Spaulding stated, "The addition of Aziz's experience and skills furthers our ability to be a 'one-stop-shop' for pharmaceutical companies throughout the world.  We continue to focus on being the innovation leader in the industry."

To learn more about how Spaulding can assist with your Clinical Pharmacology programs
'/>"/>

SOURCE Spaulding Clinical Research, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
2. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
3. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
4. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
5. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
6. OmniComm Systems Awarded 4 Clinical Trials from U.S. Biotechnology Company
7. Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
8. Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session
9. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
10. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
11. Publication in SLEEP Journal Demonstrates Positive Results of Large Multi-Center Clinical Trial for Provent® Sleep Apnea Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... COLUMBUS, Ohio, July 30, 2015 Mettler-Toledo International ... results for 2015.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... in the quarter. , Net earnings per diluted ... in the prior-year period. Adjusted EPS was $2.80 , ...
(Date:7/30/2015)... July 30, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin ... non-exclusive Development Agreements with Dexcom, Inc. to allow ... with the Dexcom G5 and G6 continuous glucose ... generation pump platform with Dexcom,s future CGM systems ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... Requests Enhancements to Risk Mitigation Strategies Consistent with ... ... (Nasdaq:,CEPH) announced today receipt of a complete response letter from ... Application,(sNDA) for FENTORA(R) (fentanyl buccal tablet) [C-II] as a treatment ...
... Theranostics Health (TH) today,announced that it has ... the,Federal Government. This, along with its Medical ... of Health & Mental Hygiene, allows the ... the,disciplines/specialties of Immunology/protein microarray and,Pathology/histopathology., The ...
Cached Medicine Technology:Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 2Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 3Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 4Theranostics Health Receives Green Light to Perform Clinical Testing 2
(Date:7/31/2015)... ... July 31, 2015 , ... Eldermark Software, the innovative ... for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper is a ... understand the benefits of using medication management technologies . , ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a new cloud based service ... Health IT as a Service (HITaaS) is a Healthcare dedicated cloud based service that ... , HITaaS manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, ...
(Date:7/31/2015)... ... ... Physical therapy for knee osteoarthritis is an important part of knee pain ... from doing what they want or need to do. The patient may have trouble getting ... patient's exercise regime may be limited by the pain in their knee. When a patient ...
(Date:7/31/2015)... ... July 31, 2015 , ... New Energy Works Timberframers invites the public to ... August 15th, 2015 from 9am – 12pm. Timber frame raisings are special, ... entire community as the culmination of months of effort, planning, fundraising, and dreaming takes ...
(Date:7/31/2015)... ... ... The Radiology Business Management Association’s 2015 Fall Educational Conference ... Care: A View From Capitol Hill” on Sunday, Sept. 27, 2015, in Austin, Tex. ... has a special understanding of the real world impact of health care policy issues,” ...
Breaking Medicine News(10 mins):Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... food safety lawyer, writes about why it is essential for ... says that there is a major defect in the food ... inhibits people affected or even killed by contaminated food products ... level, it prevents our society from knowing the source of ...
... adults, which is the most common type of myotonic dystrophy ... the University of Virginia Health System have shown for the ... acid) in muscle cells could result in the reversing myotonic ... the United States have myotonic muscular dystrophy (MMD). The disease ...
... first trimester could be associated with cardiac abnormalities in ... septal defects, Journal Birth Defects Research Part B, Trimester, ... who take non-steroidal anti-inflammatory drugs (NSAIDs) early in their ... babies with congenital defects. ,The findings of ...
... children who are highly sensitive to allergies in the first ... asthma. // ,Sabina Illi and colleagues at the University ... of exposure to allergens in early life and the effect ... function and asthma. They had reported their findings in the ...
... say that a commonly used HIV drug may be useful ... be used in prevention of the cancer and could be ... and his colleagues said that such a cream could prove ... lesions. However no clinical trials have begun as yet. ...
... Another 14 people have succumbed to an outbreak of mosquito-borne ... These deaths are in addition to the 26 people already ... around 437 people have been infected with the disease and ... more than what were detected in the first six months ...
Cached Medicine News:Health News:Importance of knowing the source of our food 2Health News:Toxic Strand Of RNA Causes Myotonic Muscular dystrophy 2Health News:NSAIDs In First trimester Linked To Congenital Anomalies In Babies 2Health News:Babies Prone To Allergies More likely To Be Asthmatic 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: